Chemokines in homeostasis and diseases

被引:147
作者
Chen, Keqiang [1 ]
Bao, Zhiyao [1 ,2 ]
Tang, Peng [1 ,3 ]
Gong, Wanghua [4 ]
Yoshimura, Teizo [5 ]
Wang, Ji Ming [1 ]
机构
[1] NCI, Canc & Inflammat Program, Ctr Canc Res, 1050 Boyles St,Bldg 560,Room 31-76, Frederick, MD 21702 USA
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Breast Surg, Chongqing 400038, Peoples R China
[4] Leidos Biomed Res Inc, Basic Res Program, Frederick, MD 21702 USA
[5] Okayama Univ, Dept Pathol & Expt Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
基金
美国国家卫生研究院;
关键词
chemokines; chemotaxis; diseases; GPCRs; homeostasis; inflammatory cells; EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; CELL LUNG-CANCER; OBSTRUCTIVE PULMONARY-DISEASE; INFLAMMATORY-BOWEL-DISEASE; RECEPTOR CXCR4 EXPRESSION; TERMINUS-TRUNCATED CXCR4; CENTRAL-NERVOUS-SYSTEM; HUMAN COLON-CANCER; PROSTATE-CANCER;
D O I
10.1038/cmi.2017.134
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
For the past twenty years, chemokines have emerged as a family of critical mediators of cell migration during immune surveillance, development, inflammation and cancer progression. Chemokines bind to seven transmembrane G protein-coupled receptors (GPCRs) that are expressed by a wide variety of cell types and cause conformational changes in trimeric G proteins that trigger the intracellular signaling pathways necessary for cell movement and activation. Although chemokines have evolved to benefit the host, inappropriate regulation or utilization of these small proteins may contribute to or even cause diseases. Therefore, understanding the role of chemokines and their GPCRs in the complex physiological and diseased microenvironment is important for the identification of novel therapeutic targets. This review introduces the functional array and signals of multiple chemokine GPCRs in guiding leukocyte trafficking as well as their roles in homeostasis, inflammation, immune responses and cancer.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 167 条
[31]   Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers [J].
El-Asmar, L ;
Springael, JY ;
Ballet, S ;
Andrieu, EU ;
Vassart, G ;
Parmentier, M .
MOLECULAR PHARMACOLOGY, 2005, 67 (02) :460-469
[32]   CCR7 Mediates Directed Growth of Melanomas Towards Lymphatics [J].
Emmett, Maxine S. ;
Lanati, Silvia ;
Dunn, Darryl B. A. ;
Stone, Oliver A. ;
Bates, David O. .
MICROCIRCULATION, 2011, 18 (03) :172-182
[33]   CCR7 regulates B16 murine melanoma cell tumorigenesis in skin [J].
Fang, Lei ;
Lee, Vivian C. ;
Cha, Emily ;
Zhang, Hong ;
Hwang, Sam T. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (04) :965-972
[34]   Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily [J].
Fox, Jamie C. ;
Nakayama, Takashi ;
Tyler, Robert C. ;
Sander, Tara L. ;
Yoshie, Osamu ;
Volkman, Brian F. .
CYTOKINE, 2015, 71 (02) :302-311
[35]  
Franco Renato, 2010, Cancer Biol Ther, V9, P423, DOI 10.4161/cbt.9.6.10996
[36]   Resolvin E1 and Chemokine-like Receptor 1 Mediate Bone Preservation [J].
Gao, Li ;
Faibish, Dan ;
Fredman, Gabrielle ;
Herrera, Bruno S. ;
Chiang, Nan ;
Serhan, Charles N. ;
Van Dyke, Thomas E. ;
Gyurko, Robert .
JOURNAL OF IMMUNOLOGY, 2013, 190 (02) :689-694
[37]   Chemokines and disease [J].
Gerard, C ;
Rollins, BJ .
NATURE IMMUNOLOGY, 2001, 2 (02) :108-115
[38]   Chemokines in autoimmune disease [J].
Godessart, N ;
Kunkel, SL .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (06) :670-675
[39]   MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B [J].
Gosling, J ;
Slaymaker, S ;
Gu, L ;
Tseng, S ;
Zlot, CH ;
Young, SG ;
Rollins, BJ ;
Charo, IF .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :773-778
[40]   Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response [J].
Gouwy, Mieke ;
Schiraldi, Milena ;
Struyf, Sofie ;
Van Damme, Jo ;
Uguccioni, Mariagrazia .
IMMUNOLOGY LETTERS, 2012, 145 (1-2) :10-14